Posts tagged “Genomics”
Genetically manipulated food remains generally safe for humans and the environment, a high-powered science advisory board declared in a report Tuesday. The project was chaired by Fred Gould, a professor at North Carolina State University.
The North Carolina Biotechnology Center works across the state to grow companies and technologies that will help to heal, fuel and feed the world. As you can imagine, we hear a lot of great stories while doing this work. And nowhere are there more stories than in Durham.
Answered prayers? Recently blessed for its work by the Pope, Bamboo Therapeutics, a recently launched life sciences venture focusing on gene therapy to treat deadly childhood neurological disorders, has raised nearly $50 million from investors. CureDuchenne Ventures LLC, a venture philanthropy organization, is among the backers.
Britain's decision to allow researchers to edit the genes of human embryos -- not to create babies but to start unraveling the earliest stages of development -- is raising new questions about the ethics of this hot new technology.
A Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease. The team operates out of the Durham Innovation District.
Every year an estimated 3 to 5 million sharks are slaughtered for a precious omega-2 oil in their livers called squalene, a clear liquid, lighter than water, that helps them float. SynShark, which has operations in NC, wants to harvest squalene from the leaves of tobacco plants that have been genetically engineered to synthesize the oil.
Bret Kopelan's daughter Rafaella, now eight, was born without skin on her feet and had to have emergency care when her skin began to blister. She suffers from a rare disease that had no effective treatments currently because it doesn't affect enough people to make it commercially viable for most drug companies. So Kopelan is hopeful that a Durham company's treatment gets to market quickly and helps his daughter.
A genetic testing laboratory recruited to the state in 2011 with help from the North Carolina Biotechnology Center is about to expand. The Sequenom Center for Molecular Medicine, a $19 million Morrisville laboratory opened in 2012, will be taking over operations of a sister lab that the company is closing in Grand Rapids, Michigan.
Quintiles, the world's largest life science services company, is going to get even bigger - but through a joint venture rather than an acquisition. The deal announced Tuesday to partner with Quest to take on No. 1 lab tester LabCorp is seen as the best way for Quintiles to capitalize on a changing market, a Q executive explains.
Some of the technologies and methods researchers say will allow humans to live far beyond today's life expectancies might seem a bit sci-fi, but last week's CED Life Science Conference presentation by a California scientist behind national headline-grabbing Human Longevity Inc. considers the equally radical inventions of the last 150 years.
Red Hat's 'cloud' practice; AT&T, Cisco link cars; Uber's buy; AT&T's mobile health move; Sony VR headsets coming
In today's Bulldog wrapup of technology and life science news: Red Hat launches a "cloud" practice offering services and technology; AT&T and Cisco team up to connect vehicles; Uber buys a mapping firm; AT&T moves into mobile connected health; and Sony to launch virtual reality headsets next year.
Ikea 'smart' furniture; Aerie's loss; EU modified crop crackdown; $11.8B chip deal; new jet tracking tech
In today's Bulldog wrapup of technology and life science news: Ikea launches "smart" furniture; Aerie Pharmaceuticals reports a loss; EU gives members power to crack down on genetically modified crops; Freescale Semiconductor is sold for $11.8 billion; and new technology will track jetliners.
Federal health officials are easing access to DNA tests used to screen parents for devastating genetic disorders that can be passed on to their children. The surprise announcement Thursday offers a path forward for Google-backed genetic testing firm 23andMe, which previously clashed with regulators over its direct-to-consumer technology.
Feeding a world population the United Nations estimates will hit 9 billion by 2050 is only one of the social problems caused by an increasing number of people, the director of of the US Department of Agriculture's National Institute of Food and Agriculture tells the AgBio Summit in Raleigh. WRAL TechWire's Allan Maurer reports the details for our Insiders.
Agrochemicals giant Syngenta is facing a growing number of lawsuits challenging its release of a genetically modified corn seed that China had not approved for import, with losses to farmers estimated to be at least $1 billion.
As NC State prepares to host the AGBIO Summit, the dean of the university's College of Agriculture and Life Sciences says the event will help showcase North Carolina as the "Mecca, the hub for agio." The theme of the event: Feeding a world of 9 billion people in 2050. And action is required, reports WRAL TechWire's Allan Maurer.
It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. And one of the emerging players is Medicago, which operates a production facility in RTP.
Pfizer is teaming up with DNA testing company 23andMe to study the possible genetic underpinnings of inflammatory bowel disease, a hard-to-treat ailment that affects an estimated 1.4 million Americans.